Ralph Vincent Boccia, MD
Hematology Oncology
Medical Oncology
Highlights
Languages
- French
- Spanish
- English
Gender
MaleAbout Ralph Vincent Boccia
Background
Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland.
Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health.
Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation.
Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly.
Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet.
Recent News Articles and Media Coverage
Selected Publications
Berdeja JG, Bauer T, Arrowsmith E, Essell J, Murphy P, Reeves JA Jr, Boccia RV, Donnellan W, Flinn I. "Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy." Br J Haematol. 2017 Feb 7. doi: 10.1111/bjh.14536.
Boccia RV, Henry DH, Belton L, Bohac C, Ghazal HH. "Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia." Cancer Med. 2016 Dec;5(12):3445-3453. doi: 10.1002/cam4.958.
Boccia RV. "Translating Research into Practice: the Prosigna® (PAM50) Gene Signature Assay." Clin Adv Hematol Oncol. 2015 Jun;13(6 Suppl 6):3-13.
Forero-Torres A, Holkova B, Goldschmidt J, Chen R, Olsen G, Boccia RV, Bordoni RE, Friedberg JW, Sharman JP, Palanca-Wessels MC, Wang Y, Yasenchak CA. "Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older." Blood. 2015 Dec 24;126(26):2798-804. doi: 10.1182/blood-2015-06-644336.
Janssens A, Tarantino M, Bird RJ, Mazzucconi MG, Boccia RV, Fernández MF, Kozak T, Steurer M, Boekhorst Pt, Dillingham K, Kreuzbauer G, Woodard P. "Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity." Acta Haematol. 2015;134(4):215-28.
Honors
- Super Doctor, Washington Post Magazine
- Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore, Castle Connolly
- Top Doctor, Washingtonian Magazine, 1/1/92
- Top Doctor, Consumers' Checkbook, 1/1/92
Memberships
- American College of Physicians
- American Society of Clinical Oncology
- American Society of Hematology
- American Society for Blood and Marrow Transplantation
Locations
- The Center for Cancer & Blood Disorders
- 6410 Rockledge Drive, Suite 660, Bethesda, MD 20817
- phone: 301-571-0019
- fax: 240-482-0555